Skip to main content

Table 7 Criteria for expedited delivery and conservative management in patients with severe preeclampsia Please also refer to Figure 6.

From: Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings

Maternal clinical data: Foetal clinical data:
Cardiovascular: Uncontrolled hypertension DBP > 110 mm Hg, retinal haemorrhage or retinal detachment
Renal: compromised renal function such as Oliguria, increase in serum creatinine (> 2 mg/dl) or decrease in creatinine clearance, Proteinuria > 3 g/24 hrs
CNS: convulsions, coma, amaurosis or visual changes, drowsiness
Blood work: Platelet count < 100,000 mm3
Liver: AST or ALT > 2 times upper limit of normal values and epigastric pain or pain in RUQ, data of hepatic insufficiency
Retardation in intrauterine growth measured by ultrasonography with evidence of foetal distress
Oligohydramnios (amniotic fluid index < 2)
Biophysical profile < 6
Abruptio placentae
Absent or reversed diastolic umbilical blood flow on Doppler
Some suggested criteria include:
Maternal clinical data: Foetal clinical data:
Cardiovascular: Controlled hypertension (< 110 mm Hg)
Renal: Proteinuria < 3
CNS: Absence of clinical data
Blood test: platelet count > 100,000 Hemodynamically and clinically stable
No retardation in intrauterine growth
BPP > 6
No evidence of foetal maturity